SPY снижается на премаркете
Ближайший уровень поддержки по SPY – 198.20 уровень сопротивления – 198.40
Z смотрим на продажу
TRLA продажа ниже 54
CRI возможен разворот при удержании 79.50
ALK смотрим на откат вверх
LMT покупка выше 170
Gapping up/down: RBS +13%, DECk and BIDU +8% after earnings, SVU +2% after Mad Money mention, PBR +1% after upgrade; AMZN -10% and V -3% after earnings, MA -1% in sympathy, XOM -1% after dg Price: null Change: null
Gapping up
In reaction to strong earnings/guidance: DTLK +19%, RBS +12.8%, ACTG +12.5%, LOGM +11.8%, QLIK +11.2%, AWAY +10.3%, ECHO +9.3%, DECK +8.5%, BIDU +7.8%, SWI +7.6%, LEA +7.5%, MLNX +6.5%, RFMD +6.3%, ALGN +6.1%, ATRC +5.6%, MKTO +5.5%, PFPT +3.7%, PSO +3.2%, COLM +2.7%, GRAM +2.7%, CTCT +2.4%, VOD +2.3%, RVBD +2.2%, UHS +2.1%, CBI +2%, HBOS +1.8%, MCO +1.6%, BLDR +0.9%, MPWR +0.9%, SPSC +0.9%, VRSN +0.8%, BJRI +0.8%.
M&A news: TRLA +0.5% (follow through premarket following yesterday's M&A spec).
Select EU financial related names showing strength following RBS update: NBG +3%, BCS +2.5%, SAN +0.9%.
Other news: ACRX +7.1% (confirms July 27, 2014 PDUFA date for Zalviso), MGNX +6.3% (still checking), KERX +4% (co announced Zerenex (ferric citrate) long-term Phase 3 study results were published in the Journal of the American Society of Nephrology), ATLS +3.3% (declared 6.5% increased quarterly distribution of $0.49 per common unit), SVU +2.4% (positive Mad Money mention), PT +2.1% (still checking), SNE +1.6% (still checking, Nikkei was up over 1% last night).
Analyst comments: PBR +0.8% (upgraded to Overweight from Equal Weight at Barclays)
Gapping down
In reaction to disappointing earnings/guidance: WCG -15.4%, BCOV -15.3%, MXIM -13.5%, LSCC -12%, INFA -11.8%, NTGR -10.8%, AMZN -10.2%, P -8.8%, KLAC -6.5%, EPR -4.8%, MTSN -4.1%, WIRE -4.1%, CB -3.5%, TPX -3.5%, FSL -3.1%, GIMO -3.1%, V -2.6%, STO -2.3%, SBUX -2.2%, XRX -2.1%, WSTG -1.9%, LPNT -1.5%, TCB -1.2%, IM -1%, KEG -0.9%, DTE -0.9%, SWFT -0.8%.
M&A news: MCEP -0.6% (acquires mature Northeastern Oklahoma Properties, announces quarterly cash distribution).
Other news: FPI -3.2% (prices ~3.71 mln share public offering of common stock at $12.50 per share), GSJK -1.7% (prices 15,280,000 common units at $23.50 per unit), MA -1.4% (following V results), MSFT -0.4% (David Sachs (co-founder of Yammer) has left MSFT, according to reports).
Analyst comments: CNC -2.1% (downgraded to Market Perform from Outperform at Wells Fargo), GSK -1.8% (downgraded at UBS), NNN -1.5% (downgraded to Neutral from Buy at Ladenburg Thalmann), GM -1.4% (downgraded to Hold from Buy at Deutsche Bank), XOM -0.7% (downgraded to Underweight from Equal Weight at Barclays).
Z смотрим на продажу
TRLA продажа ниже 54
CRI возможен разворот при удержании 79.50
ALK смотрим на откат вверх
LMT покупка выше 170
Gapping up/down: RBS +13%, DECk and BIDU +8% after earnings, SVU +2% after Mad Money mention, PBR +1% after upgrade; AMZN -10% and V -3% after earnings, MA -1% in sympathy, XOM -1% after dg Price: null Change: null
Gapping up
In reaction to strong earnings/guidance: DTLK +19%, RBS +12.8%, ACTG +12.5%, LOGM +11.8%, QLIK +11.2%, AWAY +10.3%, ECHO +9.3%, DECK +8.5%, BIDU +7.8%, SWI +7.6%, LEA +7.5%, MLNX +6.5%, RFMD +6.3%, ALGN +6.1%, ATRC +5.6%, MKTO +5.5%, PFPT +3.7%, PSO +3.2%, COLM +2.7%, GRAM +2.7%, CTCT +2.4%, VOD +2.3%, RVBD +2.2%, UHS +2.1%, CBI +2%, HBOS +1.8%, MCO +1.6%, BLDR +0.9%, MPWR +0.9%, SPSC +0.9%, VRSN +0.8%, BJRI +0.8%.
M&A news: TRLA +0.5% (follow through premarket following yesterday's M&A spec).
Select EU financial related names showing strength following RBS update: NBG +3%, BCS +2.5%, SAN +0.9%.
Other news: ACRX +7.1% (confirms July 27, 2014 PDUFA date for Zalviso), MGNX +6.3% (still checking), KERX +4% (co announced Zerenex (ferric citrate) long-term Phase 3 study results were published in the Journal of the American Society of Nephrology), ATLS +3.3% (declared 6.5% increased quarterly distribution of $0.49 per common unit), SVU +2.4% (positive Mad Money mention), PT +2.1% (still checking), SNE +1.6% (still checking, Nikkei was up over 1% last night).
Analyst comments: PBR +0.8% (upgraded to Overweight from Equal Weight at Barclays)
Gapping down
In reaction to disappointing earnings/guidance: WCG -15.4%, BCOV -15.3%, MXIM -13.5%, LSCC -12%, INFA -11.8%, NTGR -10.8%, AMZN -10.2%, P -8.8%, KLAC -6.5%, EPR -4.8%, MTSN -4.1%, WIRE -4.1%, CB -3.5%, TPX -3.5%, FSL -3.1%, GIMO -3.1%, V -2.6%, STO -2.3%, SBUX -2.2%, XRX -2.1%, WSTG -1.9%, LPNT -1.5%, TCB -1.2%, IM -1%, KEG -0.9%, DTE -0.9%, SWFT -0.8%.
M&A news: MCEP -0.6% (acquires mature Northeastern Oklahoma Properties, announces quarterly cash distribution).
Other news: FPI -3.2% (prices ~3.71 mln share public offering of common stock at $12.50 per share), GSJK -1.7% (prices 15,280,000 common units at $23.50 per unit), MA -1.4% (following V results), MSFT -0.4% (David Sachs (co-founder of Yammer) has left MSFT, according to reports).
Analyst comments: CNC -2.1% (downgraded to Market Perform from Outperform at Wells Fargo), GSK -1.8% (downgraded at UBS), NNN -1.5% (downgraded to Neutral from Buy at Ladenburg Thalmann), GM -1.4% (downgraded to Hold from Buy at Deutsche Bank), XOM -0.7% (downgraded to Underweight from Equal Weight at Barclays).
